On February 25, 2024, Aimed Alliance sent a letter to the Oregon Prescription Drug Affordability Board regarding its current patient engagement process. Specifically, our letter urged for a clearer patient engagement process, valuing lived experiences, and protecting access to rare disease treatments. Read Aimed Alliance’s letter here.
Last Updated on February 29, 2024 by Aimed Alliance
